User:Ooswesthoesbes/For those unwilling to coorporate

Still needs wikification and lovianisation. The cannabis part (to be omitted maybe) is cursive. 

(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
 * 1) This act makes provision for the regulation of all substances described as 'controlled substances'.
 * 2) Responsible prescription of of all listed substances by a medical practitioner licensed to do so by the Blackburn University School of Medicine is legalized.
 * 3) Possession of listed substances by unlicensed individuals is a criminal offence and may result in prosecution and punishment in accordance with Article 9.7.13.2. of the Constitution, after the Supreme Court Judges have taken advice from two medical practitioners licensed as described in Section 1.1. of this Act.
 * 4) If it can reasonably be established in court that the individual was in possession of listed substances with intent to distribute, the Judges shall take this into account when sentencing.
 * 5) Import, export, distribution, possession, and production of all listed substances shall be exclusive to agencies of the Federal Government or organizations licensed by the Government.
 * 6) In the latter case, Government officials shall supervise at all times import, export, distribution, possession and production by the organization. Failure by the organization to make every accomodation for said government officials shall result in a fine and withdrawal of its license.
 * 7) Any import, export, distribution, possession and production of all listed substances, under conditions other than those described by this Act, is a criminal offence.
 * 8) Any action taken that results in contralegislation under this Act by any party, where a party is defined as the whole or part of an organization, the whole or part of the Government, or a private individual, whether or not the action is undertaken by the contralegislative party, is illegal.
 * 9) Any action taken which is described as illegal under the terms of this Act may result in prosecution and punishment in accordance with Article 9.7.13.2. of the Constitution, after the Supreme Court Judges have taken advice from two medical practitioners licensed as described in Section 1.1. of this Act.
 * 10) Congress, after taking advice from the Blackburn University School of Medicine, retains the right to exempt any listed substance from some or all of the restrictions described in this Act, or to apply the same restrictions, at its discretion, to a non-listed substance.
 * 11) The following drugs are describes as controlled substances.
 * 12) Schedule one:

(b)Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of paragraph (b)(34) only, the term isomer includes the optical and geometric isomers): (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)	9815 (2) Acetylmethadol	9601 (3) Allylprodine	9602 (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)	9603 (5) Alphameprodine	9604 (6) Alphamethadol	9605 (7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine)	9814 (8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)	9832 (9) Benzethidine	9606 (10) Betacetylmethadol	9607 (11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)	9830 (12) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide	9831 (13) Betameprodine	9608 (14) Betamethadol	9609 (15) Betaprodine	9611 (16) Clonitazene	9612 (17) Dextromoramide	9613 (18) Diampromide	9615 (19) Diethylthiambutene	9616 (20) Difenoxin	9168 (21) Dimenoxadol	9617 (22) Dimepheptanol	9618 (23) Dimethylthiambutene	9619 (24) Dioxaphetyl butyrate	9621 (25) Dipipanone	9622 (26) Ethylmethylthiambutene	9623 (27) Etonitazene	9624 (28) Etoxeridine	9625 (29) Furethidine	9626 (30) Hydroxypethidine	9627 (31) Ketobemidone	9628 (32) Levomoramide	9629 (33) Levophenacylmorphan	9631 (34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)	9813 (35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)	9833 (36) Morpheridine	9632 (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)	9661 (38) Noracymethadol	9633 (39) Norlevorphanol	9634 (40) Normethadone	9635 (41) Norpipanone	9636 (42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide	9812 (43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine	9663 (44) Phenadoxone	9637 (45) Phenampromide	9638 (46) Phenomorphan	9647 (47) Phenoperidine	9641 (48) Piritramide	9642 (49) Proheptazine	9643 (50) Properidine	9644 (51) Propiram	9649 (52) Racemoramide	9645 (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide	9835 (54) Tilidine	9750 (55) Trimeperidine	9646

(c)Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Acetorphine	9319 (2) Acetyldihydrocodeine	9051 (3) Benzylmorphine	9052 (4) Codeine methylbromide	9070 (5) Codeine-N-Oxide	9053 (6) Cyprenorphine	9054 (7) Desomorphine	9055 (8) Dihydromorphine	9145 (9) Drotebanol	9335 (10) Etorphine (except hydrochloride salt)	9056 (11) Heroin	9200 (12) Hydromorphinol	9301 (13) Methyldesorphine	9302 (14) Methyldihydromorphine	9304 (15) Morphine methylbromide	9305 (16) Morphine methylsulfonate	9306 (17) Morphine-N-Oxide	9307 (18) Myrophine	9308 (19) Nicocodeine	9309 (20) Nicomorphine	9312 (21) Normorphine	9313 (22) Pholcodine	9314 (23) Thebacon	9315

(d)Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers): (1) Alpha-ethyltryptamine	7249 Some trade or other names: etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET. (2) 4-bromo-2,5-dimethoxy-amphetamine	7391 Some trade or other names: 4-bromo-2,5-dimethoxy-[alpha]-methylphenethylamine; 4-bromo-2,5-DMA (3) 4-Bromo-2,5-dimethoxyphenethylamine	7392 Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus. (4) 2,5-dimethoxyamphetamine	7396 Some trade or other names: 2,5-dimethoxy-[alpha]-methylphenethylamine; 2,5-DMA (5) 2,5-dimethoxy-4-ethylamphet-amine	7399 Some trade or other names: DOET (6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)	7348 (7) 4-methoxyamphetamine	7411 Some trade or other names: 4-methoxy-[alpha]-methylphenethylamine; paramethoxyamphetamine, PMA (8) 5-methoxy-3,4-methylenedioxy-amphetamine	7401 (9) 4-methyl-2,5-dimethoxy-amphetamine	7395 Some trade and other names: 4-methyl-2,5-dimethoxy-[alpha]-methylphenethylamine; "DOM"; and "STP" (10) 3,4-methylenedioxy amphetamine	7400 (11) 3,4-methylenedioxymethamphetamine (MDMA)	7405 (12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA	7404 (13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA	7402 (14) 3,4,5-trimethoxy amphetamine	7390 (15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT	7431 (16) Alpha-methyltryptamine (other name: AMT)	7432 (17) Bufotenine	7433 Some trade and other names: 3-([beta]-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine (18) Diethyltryptamine	7434 Some trade and other names: N,N-Diethyltryptamine; DET (19) Dimethyltryptamine	7435 Some trade or other names: DMT (20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)	7439 (21) Ibogaine	7260 Some trade and other names: 7-Ethyl-6,6[beta],7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino [5,4-b] indole; Tabernanthe iboga (22) Lysergic acid diethylamide	7315 (23) Marihuana	7360 (24) Mescaline	7381 (25) Parahexyl--7374; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl. (26) Peyote	7415 Meaning all parts of the plant presently classified botanically asLophophora williamsii Lemaire,whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12)) (27) N-ethyl-3-piperidyl benzilate	7482 (28) N-methyl-3-piperidyl benzilate	7484 (29) Psilocybin	7437 (30) Psilocyn	7438 (31) Tetrahydrocannabinols	7370 Meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: 1 cis or trans tetrahydrocannabinol, and their optical isomers 6 cis or trans tetrahydrocannabinol, and their optical isomers 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.) (32) Ethylamine analog of phencyclidine	7455 Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE (33) Pyrrolidine analog of phencyclidine	7458 Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP (34) Thiophene analog of phencyclidine	7470 Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP (35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine	7473 Some other names: TCPy

(e)Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate)	2010 (2) Mecloqualone	2572 (3) Methaqualone	2565

(f)Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: (1) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)	1585 (2) N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine)	7493 (3) Cathinone	1235 Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone (4) Fenethylline	1503 (5) Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers	1237 (6) (+/-)cis-4-methylaminorex ((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)	1590 (7) N-ethylamphetamine	1475 (8)N,N-dimethylamphetamine (also known asN,N-alpha-trimethyl-benzeneethanamine;N,N-alpha-trimethylphenethylamine)	1480

(g)Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances:

(1) 5-(1,1-Dimethylheptyl)-2-[(1R, 3S )-3-hydroxycyclohexyl]-phenol, its optical, positional, and geometric isomers, salts and salts of isomers--7297 (Other names: CP-47,497)

(2) 5-(1,1-Dimethyloctyl)-2-[(1R, 3S )-3-hydroxycyclohexyl]-phenol, its optical, positional, and geometric isomers, salts and salts of isomers--7298 (Other names: cannabicyclohexanol and CP-47,497 C8 homologue)

(3) 1-Butyl-3-(1-naphthoyl)indole, its optical, positional, and geometric isomers, salts and salts of isomers--7173 (Other names: JWH-073)

(4) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole, its optical, positional, and geometric isomers, salts and salts of isomers--7200 (Other names: JWH-200)

(5) 1-Pentyl-3-(1-naphthoyl)indole, its optical, positional, and geometric isomers, salts and salts of isomers--7118 (Other names: JWH-018 and AM678)

(6) 4-methyl-N-methylcathinone--1248

(Other names: mephedrone)

(7) 3,4-methylenedioxy-N-methylcathinone--7540

(Other names: methylone)

(8) 3,4-methylenedioxypyrovalerone--7535

(Other names: MDPV) (a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
 * 1) Schedule two:

(b)Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:

(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following: (i) Codeine	9050 (ii) Dihydroetorphine	9334 (iii) Ethylmorphine	9190 (iv) Etorphine hydrochloride	9059 (v) Granulated opium	9640 (vi) Hydrocodone	9193 (vii) Hydromorphone	9150 (viii) Metopon	9260 (ix) Morphine	9300 (x) Opium extracts	9610 (xi) Opium fluid	9620 (xii) Oripavine	9330 (xiii) Oxycodone	9143 (xiv) Oxymorphone	9652 (xv) Powdered opium	9639 (xvi) Raw opium	9600 (xvii) Thebaine	9333 (xviii) Tincture of opium	9630

(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.

(3) Opium poppy and poppy straw.

(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.

(c)Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted: (1) Alfentanil	9737 (2) Alphaprodine	9010 (3) Anileridine	9020 (4) Bezitramide	9800 (5) Bulk dextropropoxyphene (non-dosage forms)	9273 (6) Carfentanil	9743 (7) Dihydrocodeine	9120 (8) Diphenoxylate	9170 (9) Fentanyl	9801 (10) Isomethadone	9226 (11) Levo-alphacetylmethadol	9648 [Some other names: levo-alpha-acetylmethadol, levomethadyl acetate, LAAM] (12) Levomethorphan	9210 (13) Levorphanol	9220 (14) Metazocine	9240 (15) Methadone	9250 (16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane	9254 (17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid	9802 (18) Pethidine (meperidine)	9230 (19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine	9232 (20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate	9233 (21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid	9234 (22) Phenazocine	9715 (23) Piminodine	9730 (24) Racemethorphan	9732 (25) Racemorphan	9733 (26) Remifentanil	9739 (27) Sufentanil	9740 (28) Tapentadol	9780

(d)Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system: (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers	1100 (2) Methamphetamine, its salts, isomers, and salts of its isomers	1105 (3) Phenmetrazine and its salts	1631 (4) Methylphenidate	1724 (5) Lisdexamfetamine, its salts, isomers, and salts of its isomers	1205.

(e)Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Amobarbital	2125 (2) Glutethimide	2550 (3) Pentobarbital	2270 (4) Phencyclidine	7471 (5) Secobarbital	2315

(f)Hallucinogenic substances. (1) Nabilone	7379 [Another name for nabilone: (+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one]

(g)Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

(1) Immediate precursor to amphetamine and methamphetamine: (i) Phenylacetone	8501 Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;

(2) Immediate precursors to phencyclidine (PCP): (i) 1-phenylcyclohexylamine	7460 (ii) 1-piperidinocyclohexanecarbonitrile (PCC)	8603

(3) Immediate precursor to fentanyl: (i) 4-anilino-N-phenethyl-4-piperidine (ANPP)	8333

(ii) [Reserved] (a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
 * 1) Schedule three:

(b)Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances	1405 (2) Benzphetamine	1228 (3) Chlorphentermine	1645 (4) Clortermine	1647 (5) Phendimetrazine	1615

(c)Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system: (1) Any compound, mixture or preparation containing: (i) Amobarbital	2126 (ii) Secobarbital	2316 (iii) Pentobarbital	2271 or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. (2) Any suppository dosage form containing: (i) Amobarbital	2126 (ii) Secobarbital	2316 (iii) Pentobarbital	2271 or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. (3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof	2100 (4) Chlorhexadol	2510 (5) Embutramide	2020 (6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act	2012 (7) Ketamine, its salts, isomers, and salts of isomers	7285 [Some other names for ketamine: (+/-)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone] (8) Lysergic acid	7300 (9) Lysergic acid amide	7310 (10) Methyprylon	2575 (11) Sulfondiethylmethane	2600 (12) Sulfonethylmethane	2605 (13) Sulfonmethane	2610 (14) Tiletamine and zolazepam or any salt thereof	7295 Some trade or other names for a tiletamine-zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon.

(d) Nalorphine 9400.

(e)Narcotic drugs. Unless specifically excepted or unless listed in another schedule: (1) Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium	9803 (ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts	9804 (iii) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium	9805 (iv) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts	9806 (v) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts	9807 (vi) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts	9808 (vii) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts	9809 (viii) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts	9810 (2) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below: (i) Buprenorphine	9064 (ii) [Reserved]

(f)Anabolic Steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters and ethers:

(1) Anabolic steroids (see 1300.01 of this chapter)--4000

(2) [Reserved]

(g)Hallucinogenic substances. (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product--7369.

[Some other names for dronabinol: (6aR-trans )-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H -dibenzo [b,d ]pyran-1-ol] or (-)-delta-9-(trans )-tetrahydrocannabinol]

(2) [Reserved] (a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
 * 1) Schedule four:

(b)Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit	9167 (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)	9278

(c)Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Alprazolam	2882 (2) Barbital	2145 (3) Bromazepam	2748 (4) Camazepam	2749 (5) Carisoprodol	8192 (6) Chloral betaine	2460 (7) Chloral hydrate	2465 (8) Chlordiazepoxide	2744 (9) Clobazam	2751 (10) Clonazepam	2737 (11) Clorazepate	2768 (12) Clotiazepam	2752 (13) Cloxazolam	2753 (14) Delorazepam	2754 (15) Diazepam	2765 (16) Dichloralphenazone	2467 (17) Estazolam	2756 (18) Ethchlorvynol	2540 (19) Ethinamate	2545 (20) Ethyl loflazepate	2758 (21) Fludiazepam	2759 (22) Flunitrazepam	2763 (23) Flurazepam	2767 (24) Fospropofol	2138 (25) Halazepam	2762 (26) Haloxazolam	2771 (27) Ketazolam	2772 (28) Loprazolam	2773 (29) Lorazepam	2885 (30) Lormetazepam	2774 (31) Mebutamate	2800 (32) Medazepam	2836 (33) Meprobamate	2820 (34) Methohexital	2264 (35) Methylphenobarbital (mephobarbital)	2250 (36) Midazolam	2884 (37) Nimetazepam	2837 (38) Nitrazepam	2834 (39) Nordiazepam	2838 (40) Oxazepam	2835 (41) Oxazolam	2839 (42) Paraldehyde	2585 (43) Petrichloral	2591 (44) Phenobarbital	2285 (45) Pinazepam	2883 (46) Prazepam	2764 (47) Quazepam	2881 (48) Temazepam	2925 (49) Tetrazepam	2886 (50) Triazolam	2887 (51) Zaleplon	2781 (52) Zolpidem	2783 (53) Zopiclone	2784

(d)Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: (1) Fenfluramine	1670

(e)Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers: (1) Cathine ((+)-norpseudoephedrine)	1230 (2) Diethylpropion	1610 (3) Fencamfamin	1760 (4) Fenproporex	1575 (5) Mazindol	1605 (6) Mefenorex	1580 (7)Modafinil	1680 (8) Pemoline (including organometallic complexes and chelates thereof)	1530 (9) Phentermine	1640 (10) Pipradrol	1750 (11) Sibutramine	1675 (12) SPA ((-)-1-dimethylamino- 1,2-diphenylethane)	1635

(f)Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts: (1) Pentazocine	9709 (2) Butorphanol (including its optical isomers)	9720 (a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
 * 1) Schedule five:

(b)Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:

(1) [Reserved]

(c)Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.

(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.

(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.

(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.

(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.

(6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

(d)Stimulants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

(e)Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:

(1) Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]-2779

(2) Lacosamide [(R )-2-acetoamido-N -benzyl-3-methoxy-propionamide]--2746

(3) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid]--2782

(1) Pyrovalerone

1485.

(2) [Reserved] The following nonnarcotic substances which may, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301), be lawfully sold over the counter with-out a prescription, are excluded from all schedules pursuant to section 201(g) (1) of the Act (21 U.S.C. 811(g) (1)):
 * 1) Excluded nonnarcotic substances:

Excluded Nonnarcotic Products Company	Trade name	NDC code	Form	Controlled substance	(mg or mg/ml) Bioline Laboratories	Theophed	00719-1945	TB	Phenobarbital	8.00 Classic Pharmaceuticals LLC	Nasal Decongestant Inhaler/Vapor Inhaler		IN	Levmetamfetamine (l-Desoxyephedrine)	50.00 Goldline Laboratories	Guiaphed Elixir	00182-1377	EL	Phenobarbital	4.00 Goldline Laboratories	Tedrigen Tablets	00182-0134	TB	Phenobarbital	8.00 Hawthorne Products Inc	Choate's Leg Freeze		LQ	Chloral hydrate	246.67 Parke-Davis + Co	Tedral	00071-0230	TB	Phenobarbital	8.00 Parke-Davis + Co	Tedral Elixir	00071-0242	EX	Phenobarbital	40.00 Parke-Davis + Co	Tedral S.A.	00071-0231	TB	Phenobarbital	8.00 Parke-Davis + Co	Tedral Suspension	00071-0237	SU	Phenobarbital	80.00 Parmed Pharmacy	Asma-Ese	00349-2018	TB	Phenobarbital	8.10 Rondex Labs	Azma-Aids	00367-3153	TB	Phenobarbital	8.00 Smith Kline Consumer	Benzedrex	49692-0928	IN	Propylhexedrine	250.00 Sterling Drug, Inc	Bronkolixir	00057-1004	EL	Phenobarbital	0.80 Sterling Drug, Inc	Bronkotabs	00057-1005	TB	Phenobarbital	8.00 Vicks Chemical Co	Vicks Inhaler	23900-0010	IN	I-Desoxyephedrine	113.00 White Hall Labs	Primatene (P-tablets)	00573-2940	TB	Phenobarbital	8.00 (a) The chemical preparations and mixtures approved pursuant to 1308.23 are exempt from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21 U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the extent described in paragraphs (b) to (h) of this section. Substances set forth in paragraph (j) of this section shall be exempt from the application of sections 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21 U.S.C. 825-829, 952-954) and 1301.71-1301.73 and 1301.74 (a), (b), (d), (e) and (f) of this chapter to the extent as hereinafter may be provided.
 * 1) Exempted chemical preparation:

(b) Registration and security: Any person who manufactures an exempt chemical preparation or mixture must be registered under the Act and comply with all relevant security requirements regarding controlled substances being used in the manufacturing process until the preparation or mixture is in the form described in paragraph (i) of this section. Any other person who handles an exempt chemical preparation after it is in the form described in paragraph (i) of this section is not required to be registered under the Act to handle that preparation, and the preparation is not required to be stored in accordance with security requirements regarding controlled substances.

(c) Labeling: In lieu of the requirements set forth in part 1302 of this chapter, the label and the labeling of an exempt chemical preparation must be prominently marked with its full trade name or other description and the name of the manufacturer or supplier as set forth in paragraph (i) of this section, in such a way that the product can be readily identified as an exempt chemical preparation. The label and labeling must also include in a prominent manner the statement "For industrial use only" or "For chemical use only" or "For in vitro use only--not for human or animal use" or "Diagnostic reagent--for professional use only" or a comparable statement warning the person reading it that human or animal use is not intended. The symbol designating the schedule of the controlled substance is not required on either the label or the labeling of the exempt chemical preparation, nor is it necessary to list all ingredients of the preparation.

(d)Records and reports: Any person who manufactures an exempt chemical preparation or mixture must keep complete and accurate records and file all reports required under part 1304 of this chapter regarding all controlled substances being used in the manufacturing process until the preparation or mixture is in the form described in paragraph (i) of this section. In lieu of records and reports required under part 1304 of this chapter regarding exempt chemical preparations, the manufacturer need only record the name, address, and registration number, if any, of each person to whom the manufacturer distributes any exempt chemical preparation. Each importer or exporter of an exempt narcotic chemical preparation must submit a semiannual report of the total quantity of each substance imported or exported in each calendar half-year within 30 days of the close of the period to the Drug and Chemical Evaluation Section, Drug Enforcement Administration. See the Table of DEA Mailing Addresses in 1321.01 of this chapter for the current mailing address. Any other person who handles an exempt chemical preparation after it is in the form described in paragraph (i) of this section is not required to maintain records or file reports.

(e) Quotas, order forms, prescriptions, import, export, and transshipment requirements: Once an exempt chemical preparation is in the form described in paragraph (i) of this section, the requirements regarding quotas, order forms, prescriptions, import permits and declarations, export permit and declarations, and transshipment and intransit permits and declarations do not apply. These requirements do apply, however, to any controlled substances used in manufacturing the exempt chemical preparation before it is in the form described in paragraph (i) of this section.

(f) Criminal penalties: No exemption granted pursuant to 1308.23 affects the criminal liability for illegal manufacture, distribution, or possession of controlled substances contained in the exempt chemical preparation. Distribution, possession, and use of an exempt chemical preparation are lawful for registrants and nonregistrants only as long as such distribution, possession, or use is intended for laboratory, industrial, or educational purposes and not for immediate or subsequent administration to a human being or other animal.

(g) Bulk materials: For materials exempted in bulk quantities, the Administrator may prescribe requirements other than those set forth in paragraphs (b) through (e) of this section on a case-by-case basis.

(h) Changes in chemical preparations: Any change in the quantitative or qualitative composition of the preparation or mixture after the date of application, or change in the trade name or other designation of the preparation or mixture, set forth in paragraph (i) of this section, requires a new application for exemption.

(i) A listing of exempt chemical preparations may be obtained by submitting a written request to the Drug and Chemical Evaluation Section, Drug Enforcement Administration. See the Table of DEA Mailing Addresses in 1321.01 of this chapter for the current mailing address.

(j) The following substances are designated as exempt chemical preparations for the purposes set forth in this section.

(1)Chloral. When packaged in a sealed, oxygen-free environment, under nitrogen pressure, safeguarded against exposure to the air.

(2)Emit RPhenobarbital Enzyme Reagent B. In one liter quantities each with a 5 ml. retention sample for repackaging as an exempt chemical preparation only. (a) Any processed plant material or animal feed mixture containing any amount of tetrahydrocannabinols (THC) that is both:
 * 1) Exemption cannabis plant material:

(1) Made from any portion of a plant of the genus Cannabis excluded from the definition of marijuana under the Act [i.e., the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination] and

(2) Not used, or intended for use, for human consumption, has been exempted by the Administrator from the application of the Act and this chapter.

(b) As used in this section, the following terms shall have the meanings specified:

(1) The termprocessed plant material means cannabis plant material that has been subject to industrial processes, or mixed with other ingredients, such that it cannot readily be converted into any form that can be used for human consumption.

(2) The termanimal feed mixture means sterilized cannabis seeds mixed with other ingredients (not derived from the cannabis plant) in a formulation that is designed, marketed, and distributed for animal consumption (and not for human consumption).

(3) The termused for human consumption means either:

(i) Ingested orally or

(ii) Applied by any means such that THC enters the human body.

(4) The termintended for use for human consumption means any of the following:

(i) Designed by the manufacturer for human consumption;

(ii) Marketed for human consumption; or

(iii) Distributed, exported, or imported, with the intent that it be used for human consumption.

(c) In any proceeding arising under the Act or this chapter, the burden of going forward with the evidence that a material, compound, mixture, or preparation containing THC is exempt from control pursuant to this section shall be upon the person claiming such exemption, as set forth in section 515(a)(1) of the Act (21 U.S.C. 885(a)(1)). In order to meet this burden with respect to a product or plant material that has not been expressly exempted from control by the Administrator pursuant to 1308.23, the person claiming the exemption must present rigorous scientific evidence, including well-documented scientific studies by experts trained and qualified to evaluate the effects of drugs on humans.